Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
about
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
description
im August 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 14 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2018
@uk
name
Molecular predictors of preven ...... ors in the phase 3 STORM trial
@en
Molecular predictors of preven ...... ors in the phase 3 STORM trial
@nl
type
label
Molecular predictors of preven ...... ors in the phase 3 STORM trial
@en
Molecular predictors of preven ...... ors in the phase 3 STORM trial
@nl
prefLabel
Molecular predictors of preven ...... ors in the phase 3 STORM trial
@en
Molecular predictors of preven ...... ors in the phase 3 STORM trial
@nl
P2093
P50
P1433
P1476
Molecular predictors of preven ...... ors in the phase 3 STORM trial
@en
P2093
Adina Emilia Croitoru
Carol Pena
Chris Verslype
Daniela Sia
Edward Gane
Gar-Yang Chau
Gerold Meinhardt
Han Chu Lee
Joong-Won Park
Jordi Camps
P304
P356
10.1136/GUTJNL-2018-316408
P407
P50
P577
2018-08-14T00:00:00Z